Public Profile

Chattem, Inc.

Chattem, Inc., a prominent player in the consumer healthcare industry, is headquartered in the United States. Founded in 1879, the company has established itself as a leader in the development and marketing of over-the-counter (OTC) products, particularly in the areas of pain relief, skin care, and dietary supplements. With a diverse portfolio that includes well-known brands such as Gold Bond, Icy Hot, and Benadryl, Chattem distinguishes itself through innovative formulations and a commitment to quality. The company has achieved significant milestones, including its acquisition by Sanofi in 2010, which has further strengthened its market position. Operating primarily in North America, Chattem continues to expand its reach, delivering trusted solutions that enhance the health and well-being of consumers.

DitchCarbon Score

How does Chattem, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

51

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Chattem, Inc.'s score of 51 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Chattem, Inc.'s reported carbon emissions

Chattem, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may be engaged in various sustainability initiatives typical within the industry, focusing on reducing environmental impact and enhancing operational efficiency. As the landscape of corporate climate responsibility evolves, it is essential for companies like Chattem to establish measurable targets and transparent reporting to align with global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Chattem, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Chattem, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Chattem, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Abacus Health Products, Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Valeant Pharmaceuticals North America LLC

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Unilever

GB
Food products nec
Updated 1 day ago

Vi-Jon, LLC

US
Chemicals nec
Updated 1 day ago

L'Oréal S.A.

FR
Chemicals nec
Updated about 22 hours ago

Hisamitsu America Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers